Implication of protein kinase C in the orexin‐induced elevation of extracellular dopamine levels and its rewarding effect
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
In the present study, we investigated the role of orexinergic systems in the activation of midbrain dopamine neurons. In an in vitro study, exposure to either orexin A or orexin B under superfusion conditions produced a transient increase in the intracellular Ca 2+concentration through the phospholipase C (PLC)/protein kinase C (PKC) pathway via G q11 α or Gβγ subunits in midbrain cultured neurons, which were shown to be tyrosine hydroxylase (TH)‐positive cells, but not in purified midbrain astrocytes. Here we show that in vivo injection with a selective PKC inhibitor chelerythrine chloride or 2‐{8‐[(dimethylamino)methyl]‐6,7,8,9‐tetrahydropyrido[1,2‐a]indol‐3‐yl}‐3‐1‐methyl‐1H‐indol‐3‐ylmaleimide HCl (Ro‐32–0432) into the ventral tegmental area (VTA) significantly suppressed the place preference and increased levels of dopamine in the nucleus accumbens (NAcc) induced by intra‐VTA injection of orexins. These results strongly support the idea that activation of the orexin‐containing neuron in the VTA leads to the direct activation of mesolimbic dopamine neurons through the activation of the PLC/PKC pathway via G q11 α or Gβγ‐subunit activation, which could be associated with the development of its rewarding effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 1×
“Furthermore, a double-label immunohistochemical study demonstrated that morphine- or cocaineconditioned rats showed the enhancement of Fos activation in lateral hypothalamus orexin neurons (Harris et al., 2005).”
BackgroundNeurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · cited 1×
“The VTA contributes to many forms of drug reinstatement (Shalev et al., 2002).”
BackgroundBorgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · cited 1×
“Orexin potentiates N-methyl-d-aspartate (NMDA) receptor excitatory postsynaptic currents (EPSCs) in VTA dopamine neurons via activation of orexin receptors and stimulation of PLC ⁄ PKC signal transduction pathways (Borgland et al., 2006).”
BackgroundThomas, M. J., Beurrier, C., Bonci, A., & Malenka, R. C. (2001) · Nature Neuroscience · doi:10.1038/nn757 · Cited by 629 · cited 1×
“…particular, long-lasting changes at excitatory synapses in the nucleus accumbens (NAcc) and the ventral tegmental area (VTA) result from in vivo administration of drugs of abuse (Vanderschuren & Kalivas, 2000; Narita et al., 2001a; Thomas et al., 2001; Ungless et al., 2001; Borgland et al., 2004).”
Background
Cited by
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
Aston-Jones, G., Smith, R. J., Sartor, G. C., Moorman, D. E., Massi, L., Tahsili-Fahadan, P., & Richardson, K. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.106 · Cited by 389
España, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C. S., & Jones, S. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07065.x · Cited by 250
“Finally, HCRT-1 infusions into the VTA elicit DA release in the NAc and induce CPP (Narita et al., 2006, 2007), although a lack of HCRT-1 effects in the NAc core has also been reported (Vittoz & Berridge, 2006; Vittoz et al., 2008).”
BackgroundInfluentialMultiple roles for orexin/hypocretin in addiction
Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59489-1.00007-0 · Cited by 215
Orexin/hypocretin role in reward: implications for opioid and other addictions
Baimel, C., Bartlett, S. E., Chiou, L., Lawrence, A. J., Muschamp, J. W., Patkar, O., Tung, L., & Borgland, S. L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12639 · Cited by 179
“Early investigators found that non-contingent electrical stimulation of this tissue could evoke a wide variety of behavioural responses PFC HC VTANAc AMY LH dopamine orexin-dynorphin GABA glutamate Fos CREB P MOP KOP Lateral hypothalamus Orexin neuron orx dyn orx dyn glu glu orx dyn glu glu glu orx dyn glu Ventral teg…”
BackgroundInfluentialHypocretin/orexin in arousal and stress
Berridge, C. W., España, R. A., & Vittoz, N. M. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.019 · Cited by 172
“In contrast, when infused into the VTA, HCRT did produce a conditioned placepreference (Narita et al., 2007).”
Background
Metadata
- Authors
- Narita, M., Nagumo, Y., Miyatake, M., Ikegami, D., Kurahashi, K., & Suzuki, T.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2007-03
- Volume
- 25
- Issue
- 5
- Pages
- 1537-1545
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1855586171
- Cited by
- 61
- References
- 5
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.